Cargando…
Mesenchymal stem cell therapy in pulmonary fibrosis: a meta-analysis of preclinical studies
BACKGROUND: Pulmonary fibrosis (PF) is a devastating disease characterized by remodeling of lung architecture and abnormal deposition of fibroblasts in parenchymal tissue and ultimately results in respiratory failure and death. Preclinical studies suggest that mesenchymal stem cell (MSC) administrat...
Autores principales: | Li, Deng-Yuan, Li, Ru-Fang, Sun, Dan-Xiong, Pu, Dan-Dan, Zhang, Yun-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371890/ https://www.ncbi.nlm.nih.gov/pubmed/34407861 http://dx.doi.org/10.1186/s13287-021-02496-2 |
Ejemplares similares
-
Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis: Improvement with Target Combination
por: Chuang, Hong-Meng, et al.
Publicado: (2018) -
Mesenchymal stem cell therapy for paraquat poisoning: A systematic review and meta-analysis of preclinical studies
por: He, Fang, et al.
Publicado: (2018) -
Mesenchymal stem cells in idiopathic pulmonary fibrosis
por: Li, Xiaohong, et al.
Publicado: (2017) -
Efficacy of mesenchymal stem cell therapy for sepsis: a meta-analysis of preclinical studies
por: Sun, Xue-Yi, et al.
Publicado: (2020) -
Nanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice
por: Han, Meng-Meng, et al.
Publicado: (2023)